New blood cancer treatment works by selectively interfering with cancer cell signalling
in News
University
of Alberta scientists have identified the mechanism of action behind a
new type of precision cancer drug for blood cancers that is set for
human trials, according to research published today in Nature Communications.Blogger's note: subterrnews.blogspot.com does not send cookies, or collect any information on those using the blog. However, the blogspot is on google, and google may collect information, and send cookies. Many of the links that we connect to do not send out cookies or collect information, but some do. You are keying in to this blog, and you have agreed to this.
The views expressed in the articles do not necessarily represent the opinions of this blog. They are the views, and opinions of the author(s) of the article.
0 comments:
Post a Comment